435 related articles for article (PubMed ID: 30728452)
21. TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor.
Mohagheghi F; Prudencio M; Stuani C; Cook C; Jansen-West K; Dickson DW; Petrucelli L; Buratti E
Hum Mol Genet; 2016 Feb; 25(3):534-45. PubMed ID: 26614389
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis.
Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC
J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424
[TBL] [Abstract][Full Text] [Related]
23. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons.
Gopal PP; Nirschl JJ; Klinman E; Holzbaur EL
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2466-E2475. PubMed ID: 28265061
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
Shenouda M; Zhang AB; Weichert A; Robertson J
Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
[TBL] [Abstract][Full Text] [Related]
25. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing.
Wang A; Conicella AE; Schmidt HB; Martin EW; Rhoads SN; Reeb AN; Nourse A; Ramirez Montero D; Ryan VH; Rohatgi R; Shewmaker F; Naik MT; Mittag T; Ayala YM; Fawzi NL
EMBO J; 2018 Mar; 37(5):. PubMed ID: 29438978
[TBL] [Abstract][Full Text] [Related]
26. Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia.
Brown DG; Shorter J; Wobst HJ
Bioorg Med Chem Lett; 2020 Feb; 30(4):126942. PubMed ID: 31926785
[TBL] [Abstract][Full Text] [Related]
27. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
28. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
[TBL] [Abstract][Full Text] [Related]
29. Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules.
Nedelsky NB; Taylor JP
RNA; 2022 Jan; 28(1):97-113. PubMed ID: 34706979
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiological implications of RNP granules in frontotemporal dementia and ALS.
Desai P; Bandopadhyay R
Neurochem Int; 2020 Nov; 140():104819. PubMed ID: 32763254
[TBL] [Abstract][Full Text] [Related]
31. Phase to Phase with TDP-43.
Sun Y; Chakrabartty A
Biochemistry; 2017 Feb; 56(6):809-823. PubMed ID: 28112502
[TBL] [Abstract][Full Text] [Related]
32. Tethering-induced destabilization and ATP-binding for tandem RRM domains of ALS-causing TDP-43 and hnRNPA1.
Dang M; Li Y; Song J
Sci Rep; 2021 Jan; 11(1):1034. PubMed ID: 33441818
[TBL] [Abstract][Full Text] [Related]
33. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death.
Gasset-Rosa F; Lu S; Yu H; Chen C; Melamed Z; Guo L; Shorter J; Da Cruz S; Cleveland DW
Neuron; 2019 Apr; 102(2):339-357.e7. PubMed ID: 30853299
[TBL] [Abstract][Full Text] [Related]
35. TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A.
Koike Y; Pickles S; Estades Ayuso V; Jansen-West K; Qi YA; Li Z; Daughrity LM; Yue M; Zhang YJ; Cook CN; Dickson DW; Ward M; Petrucelli L; Prudencio M
PLoS Biol; 2023 Mar; 21(3):e3002028. PubMed ID: 36930682
[TBL] [Abstract][Full Text] [Related]
36. Dynamic changes and mislocalizations of neurodegenerative disease-related proteins in mice stroke model.
Liu X; Yamashita T; Shi X; Bian Y; Bian Z; Omote Y; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2020 Sep; 1742():146862. PubMed ID: 32360098
[TBL] [Abstract][Full Text] [Related]
37. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration.
Solomon DA; Stepto A; Au WH; Adachi Y; Diaper DC; Hall R; Rekhi A; Boudi A; Tziortzouda P; Lee YB; Smith B; Bridi JC; Spinelli G; Dearlove J; Humphrey DM; Gallo JM; Troakes C; Fanto M; Soller M; Rogelj B; Parsons RB; Shaw CE; Hortobágyi T; Hirth F
Brain; 2018 Oct; 141(10):2908-2924. PubMed ID: 30239641
[TBL] [Abstract][Full Text] [Related]
38. TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling.
Berson A; Sartoris A; Nativio R; Van Deerlin V; Toledo JB; Porta S; Liu S; Chung CY; Garcia BA; Lee VM; Trojanowski JQ; Johnson FB; Berger SL; Bonini NM
Curr Biol; 2017 Dec; 27(23):3579-3590.e6. PubMed ID: 29153328
[TBL] [Abstract][Full Text] [Related]
39. Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD.
Hayes LR; Kalab P
Neurotherapeutics; 2022 Jul; 19(4):1061-1084. PubMed ID: 35790708
[TBL] [Abstract][Full Text] [Related]
40. Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation.
Beijer D; Kim HJ; Guo L; O'Donovan K; Mademan I; Deconinck T; Van Schil K; Fare CM; Drake LE; Ford AF; Kochański A; Kabzińska D; Dubuisson N; Van den Bergh P; Voermans NC; Lemmers RJ; van der Maarel SM; Bonner D; Sampson JB; Wheeler MT; Mehrabyan A; Palmer S; De Jonghe P; Shorter J; Taylor JP; Baets J
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34291734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
